Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Date:9/14/2007

7 stock offering and the receipt of $10 million from AstraZeneca upon the signing of the companies' research collaboration and license agreement.

Palatin Technologies' management will discuss the fourth quarter and year end financial results for the fiscal year ended June 30, 2007 and provide an update on corporate developments during a conference call and webcast on September 18, 2007 at 10:00 a.m. ET.

Conference Call and Webcast Access Information

-- Q4-Fiscal Year 2007 Conference Call - Live 9/18/2007 at 10:00 a.m. ET

Domestic Dial-In Number 1-866-454-4203

International Dial-In Number 1-913-312-6693

-- Q4-Fiscal Year 2007 Conference Call - Replay 9/18-9/25/2007

Domestic Dial-In Number 1-888-203-1112

International Dial-In Number 1-719-457-0820

Enter Pass Code I.D. # 4280242

-- Webcast Live and Replay Access http://www.palatin.com

The webcast and replay can be accessed by logging on to the investors

section of Palatin Technologies' website at http://www.palatin.com.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' websit
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...if., Nov. 6 Calbiotech, Inc. annou...ss Innovative Research (SBIR) Phase I contract by ...d. Under terms of the agreement, Calbiotech will d...agnosis of Dengue virus. ,, Dengue virus is ... threat to military forces deployed to tropical ar...
(Date:11/6/2009)...ov. 6 Intarcia Therapeutics, Inc. ...(DUROS® continuous delivery of exenatide) pro...inth Annual Diabetes Technology Meeting in San Fra...gi-bin/prnh/20050301/SFTU126LOGO ) ,, Continu...0 Lowers Plasma Glucose, HbA1c and Reduces Weight ...
(Date:11/5/2009)...one hybrid . . . , Fuel economy ratings for th...t the www.fueleconomy.gov web site, which Oak Ri...r the U.S. Department of Energy and the U.S. Envir...icles on the best fuel economy list are hybrid ele...ighway). "This list proves that hybrids have gone ...
(Date:11/5/2009)... Nov. 5 The endangered black-foote... U.S. This rare carnivore feeds on prairie dogs. ...and often entire population die-offs in towns occu... implemented a ferret breeding program and has bee...rmerly native habitat. Unfortunately, plague can ...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...e/ - The acceptance of Peros, oral,delivery platfo...significant achievement by Benchmark Biolabs, a fu...irm., Benchmark Biolabs designed, constructed and...s production facility which is co-located on,Bench...in Lincoln, NE., By obtaining approval by the USD...
...il 15 diaDexus, Inc.,today announced the appointm... channel for its new automated PLAC Test for the H...try analyzers to U.S. hospital clinical,laboratori...by the U.S.,Food & Drug Administration (FDA) enabl...istry analyzers., The PLAC Test is the only blood...
...ally enable access to MRI exams for ...ass. and BALTIMORE, April 15 Boston,Scientific Co...privately held,company, today announced a licensin...ce imaging (MRI)-safe technology. Physician implan...devices as a primary unmet clinical,need. Under th...
Other Biology Technology:Another industry first enabled by Benchmark Biolabs - Peros' oral delivery platform and vaccine facility licensed by the USDA 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 3Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 2Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 3
(Date:11/6/2009)...Monell Center and the Chinese Academy of Sciences ...eting on Taste and Smell Research. Organized by Mo...ll be the first international meeting on taste and...f Executive Officer, American Association for the ...Science magazine, will open the meeting with a ple...
(Date:11/4/2009)...reluctant to officially endorse green tea as a can...about its protective effects, including results of...rch , a journal of the American Association for Ca...al cancer. , Vassiliki Papadimitrakopoulo, M.D....cic/Head and Neck Medical Oncology at the Universi...
(Date:11/4/2009)...ns out, hold the power to help militaries and muni...up toxic waste on test sites. , Compounds known ...k in World War II and have been used in military m... are often used to propel tank shells and act like...creased knowledge of their environmentally harmful...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 2Women underrepresented in most cancer research 48173 1Women underrepresented in most cancer research 48173 2Women underrepresented in most cancer research 48173 3Women underrepresented in most cancer research 48173 4ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 1ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 2ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 3Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3
...the second call for proposals, projects focus on e...e interface between biomedical research and genomi...pproved six RTD-projects today. They will engage a...al Institutes of Technology (ETH Zurich und EPF La..., Lausanne, Geneva and Zurich. The Friedrich-Miesc...
...oup of researchers from the LGC Chemical Metrology...ty of Oviedo, Spain, have come up with a method to...cal element (atoms with an equal number of protons...vary throughout the length of a single hair. The m...ds to track the geographical movements of people, ...
... Rochelle, NY, May 27, 2009New guidelines designed...ent, and monitoring of patients with Medullary Thy...form of thyroid cancer, have been developed by the... ahead of print in Thyroid , a peer-reviewed jour...ertpub.com ). The guidelines are available free on...
Other Biology News:Swiss Initiative in Systems Biology launches new projects 2Sulphur in just one hair could blow a terrorist's alibi 2Sulphur in just one hair could blow a terrorist's alibi 3First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal 2
Sheep Anti-Methaqualone Polyclonal Antibody, Unconjugated from Abcam
...Product Goat polyclonal to BRF2 Immunogen Synth...erminal amino acids 406-419 of Human BRF2. Reacti...et tested in other species. Background Informatio... polymerase III transcription factor complex requi...
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Anti-alpha/beta-Tubulin Antibody, Unconjugated from Cell Signaling Technology
Biology Products: